Muscle morphology and performance in master athletes::A systematic review and meta-analyses by McKendry, James et al.
 
 
Muscle morphology and performance in master
athletes:
McKendry, James; Breen, Leigh; Shad, Brandon; Greig, Carolyn
DOI:
10.1016/j.arr.2018.04.007
License:
Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Document Version
Peer reviewed version
Citation for published version (Harvard):
McKendry, J, Breen, L, Shad, B & Greig, C 2018, 'Muscle morphology and performance in master athletes: A
systematic review and meta-analyses' Ageing Research Reviews, vol. 45, pp. 62-82.
https://doi.org/10.1016/j.arr.2018.04.007
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 13. Aug. 2019
Accepted Manuscript
Title: Muscle Morphology and Performance in Master
Athletes: A Systematic Review and Meta-analyses
Authors: James Mckendry, Leigh Breen, Brandon J. Shad,
Carolyn Greig
PII: S1568-1637(18)30016-3
DOI: https://doi.org/10.1016/j.arr.2018.04.007
Reference: ARR 826
To appear in: Ageing Research Reviews
Received date: 19-1-2018
Revised date: 26-3-2018
Accepted date: 24-4-2018
Please cite this article as: Mckendry, James, Breen, Leigh, Shad, Brandon
J., Greig, Carolyn, Muscle Morphology and Performance in Master
Athletes: A Systematic Review and Meta-analyses.Ageing Research Reviews
https://doi.org/10.1016/j.arr.2018.04.007
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
Page 1 of 63 
 
Muscle Morphology and Performance in Master Athletes: A Systematic Review and 
Meta-analyses 
 
Running Title: Exercise and Health in Older Age 
 
James Mckendry a, Leigh Breen a, b, Brandon J. Shad a, Carolyn Greig a, b 
 
a School of Sport, Exercise and Rehabilitation Sciences and b MRC-Arthritis Research UK 
Centre for Musculoskeletal Ageing Research, University of Birmingham, Birmingham B15 
2TT, UK 
 
*Corresponding author: James McKendry, M.Res.  
School of Sport, Exercise and Rehabilitation Sciences and MRC-Arthritis Research UK 
Centre for Musculoskeletal Ageing Research, University of Birmingham, Edgbaston, B15 
2TT. 
Phone: (+44) 7879332731 
Email: jxm965@student.bham.ac.uk 
 
Highlights  
 Ageing athletes are a unique population, who maintain excellent health in older age.  
 This is the first systematic review and meta-analyses of data from master athletes. 
 Age-associated decrements in physical function are offset in master athletes.  
 Unfavourable fat mass gain is mitigated in master athletes.  
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Abstract 
Introduction:  The extent to which chronic exercise training preserves age-related 
decrements in physical function, muscle strength, mass and morphology is unclear. Our aim 
was to conduct a systematic review of the literature to determine to what extent chronically 
trained master athletes (strength/power and endurance) preserve levels of physical function, 
muscle strength, muscle mass and morphology in older age, compared with older and 
younger controls and young trained individuals.  
Methods: The systematic data search included Medline, EMBASE, SPORTDiscus, CINAHL 
and Web of Science databases. Inclusion criteria: i) master athletes mean exercise training 
duration ≥20 years ii) master athletes mean age of cohort >59 years) iii) at least one 
measurement of muscle mass/volume/fibre-type morphology and/or strength/physical 
function.  
Results: Fifty-five eligible studies were identified. Meta-analyses were carried out on 
maximal aerobic capacity, maximal voluntary contraction and body composition. Master 
endurance athletes (42.0 ± 6.6 ml.kg-1.min-1) exhibited VO2max values comparable with 
young healthy controls (43.1 ± 6.8 ml.kg-1.min-1, P=0.84), greater than older controls (27.1 ± 
4.3 ml.kg-1.min-1, P<0.01) and master strength/power athletes (26.5 ± 2.3 ml.kg-1.min-1, 
P<0.01), and lower than young endurance trained individuals (60.0 ± 5.4 ml.kg-1.min-1, 
P<0.01). Master strength/power athletes (0.60 (0.28 to 0.93) P<0.01) and young controls 
(0.71 (0.06 to 1.36) P<0.05) were significantly stronger compared with the other groups. 
Body fat % was greater in master endurance athletes than young endurance trained (-4.44 % 
(-8.44 to -0.43) P<0.05) but lower compared with older controls (7.11 % (5.70 to 8.52) 
P<0.01).  
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Conclusion: Despite advancing age, this review suggests that chronic exercise training 
preserves physical function, muscular strength and body fat levels similar to that of young, 
healthy individuals in an exercise mode-specific manner. 
 
Keywords: Sarcopenia, Lifelong exercise, Muscle mass, Muscle strength, Endurance 
Capacity. 
 
1. Introduction 
The UK population is projected to increase by ~25% between 2013 and 2060, from 64.1 to 
80.1 million (Mitchell et al., 2012) which heralds a demographic shift towards an ageing 
society. This changing demographic presents a significant and overwhelming challenge to 
healthcare provision in the UK (Holloszy, 2000). Indeed, although individuals are living 
longer (i.e., lifespan), many endure a large portion of their later years with a number of age-
related comorbidities (Seals et al., 2015). Extending the length of time individuals remain 
healthy and disease-free (i.e. health-span) with an emphasis on compressing morbidity is 
therefore an important focus (Seals et al., 2015). Physical function (e.g., aerobic capacity and 
muscular strength) typically declines with advancing age and this is often highlighted as a 
principal risk factor for the development of a number of degenerative chronic health 
conditions (Niccoli and Partridge, 2012). However, it has been suggested that exercise 
throughout the lifespan (i.e., ‘chronic’ exercise training) can attenuate or even prevent age-
related declines in physical function. Understanding whether, and to what extent, chronic 
exercise training preserves physical function, muscle strength, mass and morphology is of 
great importance in the pursuit of appropriate countermeasures to age-related health 
deterioration. 
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Reductions of aerobic capacity (VO2max) and muscular strength are major risk factors for all-
cause mortality in older age (Lee et al., 2011; Ortega et al., 2012; Ruiz et al., 2008). VO2max 
and muscular strength are often considered robust measures of physical function and health 
as they require successful integration of the cardiovascular, respiratory and neuromuscular 
systems (Harridge and Lazarus, 2017). The gradual decline of these bodily systems with 
ageing ultimately reduces the ability of older individuals to carry out activities of daily living 
(ADL); forcing many into a state of reduced physical independence and a poorer quality of 
life (Sonn, 1996). Delineating the relative contribution of primary ageing and environmental 
influences (or secondary ageing) to the age-related decline in physical function, muscle 
strength, mass and morphology is problematic. One aspect of secondary aging that is 
considered to be particularly influential is habitual physical activity. The majority of older 
adults reduce habitual physical activity with advancing age (Blair, 2009), and this is often 
accompanied by the presence of at least one chronic disease (Hung et al., 2011). However, a 
small sub-set of the population, referred to as master athletes, are unique in that they have 
chronically undertaken and continue to maintain high levels of physical activity, including 
structured exercise training. Indeed, Zampieri and colleagues (Zampieri et al., 2015) 
demonstrated that senior sportsmen from varied training backgrounds exhibited muscular 
strength, performance, myofibre properties and function comparable with young, healthy 
individuals. These findings suggest that chronic exercise training can preserve physical 
function and skeletal muscle properties in older age. As such, the study of Master athletes 
may allow us the opportunity to distinguish the contribution of primary and secondary ageing 
to the age-related decline in health, function and performance (Harridge and Lazarus, 2017; 
Lazarus and Harridge, 2007). However, Mackey and colleagues observed no difference in 
type I or type II fibre size between young and old regardless of training status, despite 
differences in VO2max; making it challenging to draw firm conclusions regarding the impact 
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ageing and/or chronic endurance exercise elicits on fibre area (Mackey et al., 2014). To 
further complicate the variable findings in these unique individuals, Piasecki and colleagues 
demonstrated that the loss of muscle size, strength and motor units in the Tibialis anterior 
was similar between master endurance athletes and age-matched untrained controls (Piasecki 
et al., 2016a). The inconsistent findings highlighted advocate the need for a quantitative 
summary of the existing literature surrounding the effect of chronic exercise training on 
indices of performance and skeletal muscle properties.  
Earlier comparisons between young and older individuals and master athletes have typically 
included master athletes younger than 60 y (Gent and Norton, 2013; Kusy and Zielinski, 
2014; Maffulli et al., 1994). Specifically, this systematic review will focus on master athletes 
60 y or older as these individuals would typically have begun to experience age-related 
decrements in physical function, muscle strength, mass and morphology (Doherty, 2003; 
Janssen et al., 2000). Additionally, most systematic review comparisons between young and 
older individuals and master athletes have focused on single outcome measures, specifically 
body composition (Ballor and Keesey, 1991), aerobic capacity (Fitzgerald et al., 1997; 
Wilson and Tanaka, 2000), muscular strength (Peterson et al., 2010) adaptations to training 
(Daskalopoulou et al., 2017) and protein supplementation (Doering et al., 2015). Therefore, 
the primary aim of this systematic review was to establish whether older individuals who 
have undertaken chronic exercise training, preserve physical function, muscular strength, 
mass and fibre properties (i.e. size and relative distribution) compared with untrained age-
matched individuals, as well as younger trained and untrained individuals. A secondary aim 
was to determine the influence of exercise modality (i.e., strength/power vs. endurance) on 
the included parameters. 
 
2. Methods  
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2.1. Information sources and literature search 
A systematic literature search of online databases was conducted in November 2017 using 
selected key words, free text terms, indexed terms, and Boolean operators. The search 
strategies were applied to Medline, EMBASE, SPORTDiscus, CINAHL and Web of Science 
databases. Recursive searching of the bibliographies of eligible studies and relevant reviews 
was performed to identify additional articles. The systematic review was conducted in 
accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) report (Moher et al., 2009).  
 
2.2. Study Selection Criteria 
2.2.1. Inclusion Criteria 
Studies were included in the review if they met the following inclusion criteria: 1) Exercise 
training for a minimum of 20 years in the master athletes group, explicitly stated within the 
study. 2) Mean age of older cohorts older than59 years. 3) Inclusion of at least one 
measurement of muscle mass/volume/fibre type morphology (fibre type, size, area) and/or a 
measurement of strength/physical function. 4) Muscle mass measurement using magnetic 
resonance imaging (MRI), computed tomography (CT), dual x-ray absorptiometry (DXA), air 
displacement plethysmography (BodPod), hydrostatic weighing, bioelectrical impedance 
analysis (BIA) or B-Mode ultrasonography.  Physical function/strength/performance 
measurements to include one, or more, of: handgrip strength, isometric/isotonic 
strength/power/torque or aerobic capacity (VO2max). 5) Freedom from any neurological, 
neuromuscular, cardiovascular and metabolic disease. 6) Studies published only in English 
with no date restrictions. 
2.2.2. Exclusion Criteria 
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Studies were excluded from the review if: 1) The authors did not explicitly state the length of 
time that master athletes had been continuously training, or if that time was less than 20 
years. 2) No inclusion of relevant measures of muscle mass/morphology or physical function. 
3) Relevant data could not be obtained directly from potentially eligible articles or via contact 
with the study authors.  
 
2.3. Participant criteria  
Sedentary older control groups were required to be of a similar age to master athlete groups 
(mean group >59 years) and have undertaken little, to no, structured exercise training. Older 
control groups did not have to be completely sedentary compared with master athlete groups. 
Young controls were required to be younger than 40 years, and have undertaken little to no 
structured exercise training. Young controls did not have to be completely sedentary 
compared with young trained individuals, who were required to be younger than 40 years and 
undertaking either structured endurance or strength/power-based exercise training.  
2.4. Study Selection  
Titles and abstracts were screened for relevance by 2 reviewers (J.M. and B.J.S). Irrelevant 
titles were removed. Full-text articles were obtained for potentially relevant studies via a 
combination of online databases, hardcopy sourcing and direct contact with the authors, and 
these were further evaluated to determine whether they met the inclusion criteria. Studies 
deemed eligible were included in the systematic review. Two reviewers (J.M and B.J.S.) 
independently assessed full-texts for eligibility; any disagreements between the two 
reviewers were settled by consensus. All records were managed using the reference software 
EndNote (Thomson Reuters, v.X7) 
2.5. Data Extraction 
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Predetermined variables were extracted from each of the included studies using a customised 
data extraction form (J.M and B.J.S). Measures of interest included participant characteristics 
(number, age, and anthropometrics), training type and duration, measurements of muscle 
mass, physical function (strength, aerobic capacity) and fibre-type characteristics along with 
various aspects of study design/assessment (measurement tool or analytical method). In 
situations where the necessary data could not be obtained, either directly from the article or 
by contacting the corresponding authors of the paper, the study (or particular outcome 
measure) was excluded from review and/or meta-analysis.  Where BMI was not reported, it 
was calculated manually from the reported mean height and weight of the study groups.  
2.6. Data Syntheses & Statistical Analyses  
Statistical analyses were dependent upon the number of studies obtained and the associated 
outcomes measures in the relevant studies. If sufficient studies incorporating an eligible 
analytical protocol were identified for a single outcome measure (e.g., VO2max), a meta-
analysis was conducted. In cases where insufficient data were available from eligible studies 
to conduct a meta-analysis for a single outcome measure (e.g., muscle mass), findings were 
presented narratively/qualitatively.   
 
Meta-analyses were performed on studies (and variables) which included direct comparisons 
(within study) between master athletes (power/endurance) and a non-exercising older 
controls (older control) or young trained/non-trained groups. Meta-analyses were carried out 
with a random effects model using RevMan software (Review Manager (RevMan) V.5.3. 
Copenhagen, The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). Data in 
meta-analyses were presented as mean differences (MD)/standardised mean differences 
(SMD) ± 95% confidence interval (CI). Standardised mean differences were presented only 
for outcomes reported using non-comparable scales (i.e. muscular strength). All data were 
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presented as mean ± SD, along with the number of studies/study groups reporting that 
particular variable and the number of participants included in that comparison.  
 
3. Results  
3.1. Study Selection 
A total of 14,572 studies were identified by the extensive literature search and a further 1 
study was identified by manual searching of reference lists. Following removal of duplicates, 
393 study titles and abstracts were screened resulting in 143 articles being excluded from the 
review; leaving 250 full texts to be independently screened (J.M and B.J.S). Figure 1 
highlights the study identification, screening process and reasons for study exclusion.  
3.2. Study Characteristics 
The 55 included studies demonstrated substantial heterogeneity regarding the outcome 
measures and methodology (Table 1). Further, the participant characteristics displayed 
substantial incongruity, specifically the mode and level of exercise training, and the number 
of years training experience (Table 2).  Twenty-one studies included young untrained control 
groups, 43 studies included 44 older control groups, 2 studies each included a young 
strength/power trained group, 11 studies included 12 endurance trained young groups and all 
studies included at least one master endurance and/or strength/power training group. 
3.3. Participant Characteristics  
The 55 eligible studies included 2449 participants (2181 were Male and 268 Female). In 
short, included groups were master endurance athletes (67.3 ± 5.1 years, 1.73 ± 0.04 m, 71.6 
± 5.2 kg, 56 study groups, n=958) and master power athletes (71.7 ± 4.8 years, 1.73 ± 0.03 m, 
76.2 ± 8.0 kg, 15 study groups, n=218), older controls (67.9 ± 4.5 years, 1.73 ± 0.03 m, 78.2 
± 6.2 kg, 44 study groups, n=746), young endurance trained (25.4 ± 3.1 years, 1.79 ± 0.03 m, 
70.1 ± 5.0 kg, 13 study groups, n=143), young power trained (26.0 ± 1.6 years, 1.80 ± 0.02 
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m, 77.0 ± 0.4 kg, 3 study groups, n=47) and young controls (26.6 ± 3.9 years, 1.79 ± 0.03 m, 
75.9 ± 5.0 kg, 23 study groups, n=337). The participant characteristics and anthropometrics 
of the sub-groups included in the review are outlined in detail in Table 2.  
 
3.4. Training characteristics  
Experience – Master athletes had been training for 31.1 ± 9.3 (56 study groups, n=958) and 
35.6 ± 9.6 (15 study groups, n=218) years for endurance and strength/power groups, 
respectively. Young athletes had been training for 6.1 ± 2.6 (13 study groups, n =143) and 
11.2 ± 5.5 (3 study groups, n=47) years for endurance and strength/power groups, 
respectively. 
Frequency - The included groups reported similar training frequency 4.6 ± 1.4, 3.6 ± 1.1, 5.0 
± 0.8 and 4.1 ± 2.5 times per week, for master endurance (21 study groups, n=339), master 
strength/power (7 study groups, n=111), young endurance (4 study groups, n=66) and young 
strength/power trained groups (2 study groups, n=35), respectively.  
Duration – The included groups reported a similar number of training hours per week; 
master endurance 6.8 ± 3.0 h (19 study groups, n=298), master strength/power 6.3 ± 0.7 h (8 
study groups, n=164) young endurance 7.7 ± 3.6 h (6 study groups, n=45) and young 
strength/power 10.0 ± 2.1 h (2 study groups, n=42), respectively.   
Distance - Seventeen study groups of master endurance (44.5 ±10.8 km, n=302) and 3 study 
groups of young endurance trained athletes (44.7 ± 2.9 km, n=30) completed similar weekly 
cycling distances. 
3.5. Fat-Free Mass 
A total of 12 studies (Carrick-Ranson et al., 2014a; DubÉ et al., 2016; Hawkins et al., 2001; 
Hayes et al., 2015; Marcell et al., 2003; Marcell et al., 2014; Pollock et al., 2015; Proctor and 
Joyner, 1997; Sanada et al., 2009; Tarpenning et al., 2004b; Trappe et al., 2013; Yataco et al., 
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1997) reported indices of whole body fat-free mass (FFM) using DXA, hydrostatic weighing 
or bioelectrical impedance. Nineteen study groups included master endurance athletes (55.2 ± 
6.1 kg FFM, n=366), 5 study groups included older controls (54.5 ± 7.7 kg FFM, n=122), 1 
study group included young controls (53.8 ± 5.7 kg FFM, n=23) and 4 study groups included 
young endurance trained individuals (54.8 ± 7.3 kg FFM, n=56).  
 
3.6. Fat Mass 
Only three studies (DubÉ et al., 2016; Schmidt et al., 2015; Yataco et al., 1997) reported 
measures of whole-body fat mass (FM) measured using DXA or hydrostatic weighing. Three 
study groups included master endurance athletes (14.1 ± 3.6 kg FM, n=91), 2 study groups 
included older untrained individuals (20.1 ± 6.3 kg FM, n=65) and 1 study group included 
young endurance trained individuals (12.0 ± 4.2 kg FM, n=14).  
 
3.7. Body Fat Percentage 
A meta-analysis was conducted for body fat % for studies that made direct comparisons with 
master endurance athletes (Figure 2); this allowed for the greatest number of within-study 
comparisons to be incorporated into the statistical analysis. Twenty-nine studies (Aagaard et 
al., 2007; Arbab-Zadeh et al., 2004; Ari et al., 2004; Bjork et al., 2012; Buford et al., 2010; 
Buyukyazi, 2004; Carrick-Ranson et al., 2014b; Cristea et al., 2008; DubÉ et al., 2016; 
Hawkins et al., 2001; Hayes et al., 2015; Katzel et al., 1998; Korhonen et al., 2006; Korhonen 
et al., 2012; Marcell et al., 2003; Marcell et al., 2014; Matelot et al., 2016; Mortensen et al., 
2012; Nyberg et al., 2012; Ojanen et al., 2007; Pollock et al., 2015; Proctor and Joyner, 1997; 
Sallinen et al., 2008; Sanada et al., 2009; Schmidt et al., 2015; Tarpenning et al., 2004a; 
Trappe et al., 2013; Witkowski et al., 2010; Yataco et al., 1997) reported data for body fat 
percentage measured using bioelectrical impedance, DXA, hydrostatic weighing or multiple-
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site skinfold. Thirty study groups included master endurance athletes (19.7 ± 3.8 %, n=594), 
11 study groups included master strength/power athletes (16.4 ± 4.4 %, n=136), 19 study 
groups older control (24.5 ± 4.6 %, n=361), 5 study groups included young endurance trained 
(15.4 ± 5.2 %, n=63), 2 study groups included young strength/power trained individuals (14.1 
± 3.5 %, n=42) and 8 study groups included young controls (17.4 ± 3.0 %, n=126). 
Master endurance athletes had a significantly lower body fat % than older control individuals 
(P<0.01), and a significantly greater body fat % than young endurance trained (P<0.05). No 
significant differences were observed in the body fat % between master endurance athletes 
when compared with young controls and master strength/power athletes. Young 
strength/power trained individuals were not included in the meta-analyses as no eligible 
studies made direct within-study comparisons with the other included groups. 
 
3.8. Maximal Oxygen Consumption (VO2max) 
A meta-analysis was conducted for VO2max for studies that made direct comparisons with 
master endurance athletes (Figure 3); this allowed for the greatest number of within-study 
comparisons to be incorporated into the statistical analysis. VO2max was measured in 43 
studies (Aagaard et al., 2007; Anselme et al., 1994; Arbab-Zadeh et al., 2004; Ari et al., 
2004; Bhella et al., 2014; Bjork et al., 2012; Buford et al., 2010; Buyukyazi, 2004; Carrick-
Ranson et al., 2014b; DubÉ et al., 2016; Franzoni et al., 2005; Galetta et al., 2005; Galetta et 
al., 2006; Hawkins et al., 2001; Hayes et al., 2015; Katzel et al., 1998; Katzel et al., 2001; 
Mackey et al., 2014; Marcell et al., 2003; Marcell et al., 2014; Matelot et al., 2016; 
Mikkelsen et al., 2013; Molmen et al., 2012; Mortensen et al., 2012; Mucci et al., 1999; 
Nyberg et al., 2012; Ojanen et al., 2007; Pollock et al., 2015; Prasad et al., 2007; Prefaut et 
al., 1994; Proctor and Joyner, 1997; Rivier et al., 1994; Sanada et al., 2009; Schmidt et al., 
2015; Shibata and Levine, 2012; Sundstrup et al., 2010; Suominen and Rahkila, 1991; 
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Tarpenning et al., 2004a; Thomas et al., 2013; Trappe et al., 2013; Witkowski et al., 2010; 
Yataco et al., 1997) using treadmill or cycle/rowing ergometer protocols. All studies reported 
the data relative to bodyweight (ml.kg-1.min-1). Forty-nine study groups included master 
endurance athletes (42.0 ± 6.6 ml.kg-1.min-1, n=889), 3 study groups included master power 
athletes (26.5 ± 2.3 ml.kg-1.min-1, n=37), 32 study groups included older controls (27.1 ± 4.3 
ml.kg-1.min-1, n=602), 13 study groups included young endurance trained individuals (60.0 ± 
5.4 ml.kg-1.min-1, n=143) and 16 study groups included young controls (43.1 ± 6.8 ml.kg-
1.min-1, n=221). VO2max was higher in master endurance athletes than older controls 
(P<0.0001) and master power athletes (P=0.0005). VO2max was higher in endurance trained 
young than all other groups (P < 0.01). VO2max was higher in young controls than older 
controls (P<0.01) and master strength/power athletes (P<0.01). No significant differences 
were observed between young controls and master endurance athletes or between older 
controls and master strength/power athletes.  Young strength/power trained individuals were 
not included in the meta-analyses as no eligible studies made direct within-study comparisons 
with the other included groups. 
 
3.9. Strength 
Maximal voluntary contraction (MVC) was measured in 16 studies (Aagaard et al., 2007; 
Couppe et al., 2014; Korhonen et al., 2006; Korhonen et al., 2012; Marcell et al., 2014; 
Mikkelsen et al., 2013; Mosole et al., 2014; Pollock et al., 2015; Power et al., 2012; Power et 
al., 2010b; Sanada et al., 2009; Sipila and Suominen, 1991; Stenroth et al., 2016; Sundstrup 
et al., 2010; Suominen and Rahkila, 1991; Tarpenning et al., 2004a; Zampieri et al., 2015); 9 
studies with 22 study groups were included in a meta-analysis. A meta-analysis was 
conducted for studies that made direct comparisons with master endurance athletes (Figure 
4); to allow for the greatest number of within-study comparisons to be incorporated into the 
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statistical analysis. Due to the diversity of measurement scales/methods of assessment (i.e. 
knee extension, plantar flexion, elbow flexion and handgrip dynamometry) data are presented 
as SMD ± 95% CI in figure 4. MVC was significantly greater in master strength/power 
athletes (0.60 (0.28, 0.93)) and young healthy controls (0.71 (0.06, 1.36)) than master 
endurance athletes P<0.01 and P<0.05, respectively. No significant differences were 
observed in MVC between master endurance athletes when compared with older controls and 
young endurance trained individuals. Young strength/power trained individuals were not 
included in the meta-analyses as no eligible studies made direct within-study comparisons 
with the other included groups. 
 
3.10. Muscle Architecture 
Three studies reported muscle architecture outcomes (Korhonen et al., 2006; Ojanen et al., 
2007; Sipila and Suominen, 1991); included in those studies were measurements of muscle 
thickness (3 studies) and fascicle length (1 study). Of the studies that measured muscle 
thickness, one study (Korhonen et al., 2006) used the midpoint of the vastus lateralis in 
young controls 18-33 y (2.61 ± 0.08 cm, n=16) and master sprinters of 60-69 (2.1 ± 0.09 cm, 
n=21) and 70-84 y (1.96 ± 0.08 cm, n=20). Another study (Ojanen et al., 2007) summed 
muscle thickness measurements of the vastus lateralis and vastus intermedius in master 
throwers of 65 (3.9 ± 0.7 cm, n=12) and 70 (3.7 ± 0.7 cm, n=9) years compared with older 
controls, 60 (3.8 ± 0.4 cm, n=10) and 75 (3.1 ± 0.2 cm, n=5), with no differences between the 
groups. The final study (Sipila and Suominen, 1991)  measured muscle thickness of the 
rectus femoris, finding no difference between master strength/power athletes (2.73 ±0.37 cm, 
n=7), master endurance athletes (2.77 ± 0.39 cm, n=14) and older controls (2.8 ± 0.56 cm, 
n=11). One study (Korhonen et al., 2006) included measurements of vastus lateralis fascicle 
length which identified no significant differences between the groups of 18-33 year olds 
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(7.91 ± 0.49 cm, n=16), 60-69 (7.99 ± 0.27 cm, n=21) and 70-84 (7.38 ± 0.27 cm, n=20) year 
old sprint athletes.  
 
3.11. Muscle Cross-Sectional Area 
Four studies (Couppe et al., 2014; Mikkelsen et al., 2013; Rantalainen et al., 2014; Sipila and 
Suominen, 1991)  reported muscle CSA; two of which used MRI at the mid-thigh level, 
another used mid-thigh CSA with B-mode ultrasonography and another study used p-QCT to 
measure mid-tibia muscle CSA. Mid-thigh muscle CSA was reported in two studies, which 
highlighted muscle size being greater in younger individuals compared with older individuals 
and also greater in trained individuals compared with untrained controls; young endurance 
trained (7859 ± 636 mm2, n=10), young controls (6792 ± 696 mm2, n=12), master endurance 
trained (6481 ±775 mm2, n=15) and older controls (5504 ± 727 mm2, n=12) (Couppe et al., 
2014; Mikkelsen et al., 2013). Muscle CSA measured using ultrasonography in another study 
did not identify any differences between master power athletes (5250 ± 1080 mm2, n=7), 
master endurance athletes (5270 ± 880 mm2, n=14) or older controls (4840 ±1110 mm2, 
n=11) (Sipila and Suominen, 1991).  CSA of the mid-tibia region indicated that exercising 
individuals have a larger muscle CSA than non-exercising individuals and young individuals 
have a larger mid-tibia muscle CSA than older controls with no age-group interaction 
observed (Rantalainen et al., 2014); young power athletes (7140 ± 820 mm2, n=26), young 
control (7040 ± 1310 mm2, n=41), master power athletes (6270 ± 910 mm2, n=35), older 
controls (5890 ± 890 mm2, n=24).  
 
3.12. Muscle Fibre Area 
In total 9 studies (Aagaard et al., 2007; Cristea et al., 2008; Korhonen et al., 2006; Larsson et 
al., 1997; Mackey et al., 2014; Mosole et al., 2014; Sundstrup et al., 2010; Tarpenning et al., 
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2004a; Zampieri et al., 2015) measured muscle fibre morphology (type/distribution), 
including measures of type I, type II, type IIa, type IIx, type IIax and denervated fibres; using 
a variety of analytical techniques (Table 1). Type 1 fibre area was reported in 5 groups of 
master endurance athletes (5367 ± 588 µm2, n=74), 4 groups of master power athletes (4750 
± 1273 µm2, n=34), 3 groups of older controls (5488 ± 459 µm2, n=28), 2 groups of young 
controls (4282 ± 26 µm2, n=28) and 1 group of young endurance athletes (5550 ± 1337 µm2, 
n=10).  
Type 2 fibre area was reported in 3 groups of master endurance athletes (4478 ± 347 µm2, 
n=55), 1 group of older controls (4149 ± 903 µm2, n=12) 1 group of young controls (4783 ± 
872 µm2, n=12) and 1 group of young endurance trained (5498 ± 1559 µm2, n=10).  
Type 2a fibre area was reported in 2 groups of master endurance athletes (5043 ± 41 µm2, 
n=19), 4 groups of master strength/power athletes (4755 ± 1404 µm2, n=34), 2 groups of 
older controls (5411 ± 484 µm2, n=16) and 1 young control group (4700 ± 560 µm2, n=16).  
Type 2x fibre area was reported in 2 groups of master endurance athletes (3955 ± 88 µm2, 
n=19), 4 groups of master strength/power athletes (4019 ± 990 µm2, n=34), 2 groups of older 
controls (3794 ± 0 µm2, n=16) and 1 young control group (3200 ± 2720 µm2, n=16).  
Type 2ax fibre area was reported in 1 young control group (3700 ± 760 µm2, n=16) and 3 
groups of master strength/power athletes (4120 ± 495 µm2, n=27). 
 
3.13. Muscle Fibre Distribution 
Type 1 fibre distribution was reported in 7 groups of master endurance athletes (60.8 ± 10.7 
%, n=96), 5 groups of master strength/power athletes (48.0 ± 8.0 %, n=59), 6 groups of older 
controls (49.8 ± 4.2 %, n=45), 4 young control groups (43.5 ± 4.5 %, n=37), and 2 young 
endurance trained groups (51.5 ± 13.4 %, n=15). 
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Type 2 fibre distribution was reported in 5 groups of master endurance athletes (38.4 ± 11.3 
%, n=77), 3 groups of older controls (50.3 ± 4.0 %, n=27), 2 young control groups (53.5 ± 
5.0 %, n=17) and 2 young endurance trained groups (48.6 ± 13.5 %, n=15).  
Type 2a fibre distribution was reported in 2 groups of master endurance athletes (32.6 ± 10.7 
%, n=19), 5 groups of master strength/power athletes (31.8 ± 3.8 %, n=59), 2 groups of older 
controls (23.5 ± 0 %, n=16) and 1 young control group (35 ± 12 %, n=16).  
Type 2x fibre distribution was reported in 3 groups of master endurance athletes (10.3 ± 2.7 
%, n=21), 5 groups of master strength/power athletes trained individuals (10.7 ± 4.1 %, 
n=59) 3 groups of older controls (22.2 ± 13.1 %, n=18) and 2 young control groups (7.5 ± 6.4 
%, n=20). 
 
Type 2ax fibre distribution was reported in 2 groups of master endurance athletes (6.3 ± 8.1 
%, n=9), 4 groups of master strength/power athletes (11.6 ± 2.6 %, n=52), 2 groups of older 
controls (5.9 ± 5.8 %, n=8), 2 young control groups (12.0 ± 00 %, n=20) and 1 groups of 
young endurance trained individuals (0.5 ± 0.6 %, n=5). 
The percentage of denervated fibres, defined as fibre size smaller than 30µm, was reported in 
2 groups of master endurance athletes (1.9 ± 0.1 %, n=22), 2 groups of older controls (5.3 ± 
1.8 %, n=15) 1 young control group (0.3 ± 0.0 %, n=5) nand1 young endurance trained group 
(0.4 ± 0.5 %, n=5). 
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4. Discussion 
To our knowledge, this is the first systematic review and meta-analyses to focus on the effect 
of long-term exercise (i.e., endurance or strength/power) on physical function, muscular 
strength, muscle mass and morphology, to understand whether chronic exercise training 
preserves these parameters compared with age-matched untrained individuals, as well as 
younger trained and untrained individuals. There has been considerable debate about the 
relative contribution of primary and secondary ageing to the deterioration in performance and 
skeletal muscle parameters and whether or not this deterioration is inevitable in ageing. Our 
principal findings demonstrate that master endurance athletes are able to completely prevent 
the decline in VO2max found in age-matched untrained individuals; to values similar to those 
observed in young untrained individuals. In addition, we demonstrate that master 
strength/power athletes possess greater strength compared with age-matched master 
endurance athletes and untrained individuals; comparable with young untrained individuals. 
Further, all master athletes maintained a similar body fat percentage to untrained young 
controls, whereas untrained older individuals had a higher body fat percentage than 
endurance trained young. In the absence of structured exercise training, many older 
individuals displaying impairments in exercise performance and functional capacity (Tanaka 
and Seals, 2008), increased fat and reduced lean mass (Evans and Campbell, 1993) and 
changes to muscle fibre morphology (i.e. fibre atrophy and shifts in fibre sub-type) (Zampieri 
et al., 2015). Nevertheless, our findings, as well as those of others, demonstrate that older 
individuals maintain the capacity to adapt to exercise stimuli (Malbut et al., 2002; Newton et 
al., 2002). The results from this review highlight that regardless of the exercise modality (i.e., 
endurance or strength/power), chronic exercise training delays the canonical age-related 
deterioration in physical function and body composition. The maintenance/continuation of 
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structured exercise training into older age may therefore be seen as the cornerstone to optimal 
ageing and extension of the health-span in our ageing population.   
 
4.1. VO2max  
The reductions in function of multiple bodily systems observed with ageing leads to a decline 
of VO2max at a rate of equivalent to ~10-12% per decade (or ~1% per annum)  (Rogers et al., 
1990). Cardiorespiratory fitness is independently associated with all-cause mortality 
regardless of age, smoking status, body composition, and other risk factors (Lee et al., 2010; 
Lee et al., 2011) and thus a high VO2max may be protective against premature mortality. 
Meta-analysis comparisons revealed a 57% (15.4 ml.kg-1.min-1) greater VO2max in master 
endurance athletes compared with age-matched untrained individuals. Furthermore, master 
endurance athletes exhibited a greater VO2max (7.8 ml.kg-1.min-1) than master strength/power 
athletes. Collectively, these findings highlight that age-related declines in VO2max can be 
prevented by chronic exercise in an exercise mode-specific manner. 
 
The reductions in VO2max reported in master athletes appear to begin at the same age and 
decline at a similar (Faulkner et al., 2008; Wilson and Tanaka, 2000), if not greater ((Eskurza 
et al., 2002; Fitzgerald et al., 1997; Tanaka et al., 1997)), rate compared with age-matched 
untrained individuals; providing evidence that despite continuous endurance exercise training 
there is an unavoidable decline of aerobic capacity. It is proposed that as age progresses, 
master athletes undergo a greater alteration to their activity status (e.g. training intensity and 
volume) (Eskurza et al., 2002; Fitzgerald et al., 1997), which may underpin the accelerated 
rate of decline in VO2max observed (Eskurza et al., 2002; Tanaka et al., 1997). However, the 
studies included in the current review highlighted no observable difference in training 
frequency (Aagaard et al., 2007; Bhella et al., 2014; Buyukyazi, 2004; Carrick-Ranson et al., 
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2014b; Couppe et al., 2014; DubÉ et al., 2016; Franzoni et al., 2005; Galetta et al., 2005; 
Galetta et al., 2006; Korhonen et al., 2006; Korhonen et al., 2012; Larsson et al., 1997; 
Marcell et al., 2003; Marcell et al., 2014; Molmen et al., 2012; Ojanen et al., 2007; Power et 
al., 2010b; Sallinen et al., 2008; Sanada et al., 2009; Sipila and Suominen, 1991; Sundstrup et 
al., 2010; Witkowski et al., 2010; Yataco et al., 1997; Zampieri et al., 2015), distance (Arbab-
Zadeh et al., 2004; Couppe et al., 2014; Hawkins et al., 2001; Mackey et al., 2014; Marcell et 
al., 2003; Marcell et al., 2014; Mikkelsen et al., 2013; Power et al., 2010b; Shibata and 
Levine, 2012; Stenroth et al., 2016; Suominen and Rahkila, 1991; Tarpenning et al., 2004a; 
Thomas et al., 2013; Witkowski et al., 2010) and session duration (Ari et al., 2004; Bjork et 
al., 2012; Buford et al., 2010; Buyukyazi, 2004; Carrick-Ranson et al., 2014b; Couppe et al., 
2014; Korhonen et al., 2006; Korhonen et al., 2012; Matelot et al., 2016; Mortensen et al., 
2012; Mosole et al., 2014; Mucci et al., 1999; Nyberg et al., 2012; Proctor and Joyner, 1997; 
Rantalainen et al., 2014; Rivier et al., 1994; Sanada et al., 2009; Schmidt et al., 2015; 
Stenroth et al., 2016; Suominen and Rahkila, 1991; Trappe et al., 2013; Zampieri et al., 2015) 
between younger and older endurance athletes; although alterations to training intensity 
cannot be excluded as none were reported. VO2max values included in this meta-analysis were 
~32% lower in master endurance athletes (42  6.6 ml.kg-1.min-1) than young endurance 
trained individuals (62.0  5.4 ml.kg-1.min-1), which is supported by recent research 
demonstrating an inescapable reduction in VO2max in master endurance athletes, despite 
continuous levels of endurance exercise training (Everman et al., 2018). It is beyond the 
scope of this review to identify the relative rate of decline in VO2max as no longitudinal 
studies were incorporated. Regardless of the rate at which VO2max declines with age, the 
maintenance of endurance-type exercise and thus cardiorespiratory fitness are paramount to 
offset age-associated health decrements. The greater VO2peak in these highly trained master 
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athletes may therefore allow larger reductions to occur before reduced physical capacity and 
functional independence is compromised, compared with age-matched untrained individuals.  
 
Although not established in the current review, it is generally acknowledged that reduced 
physical activity is a key contributor towards the development of disease, disability and 
physical dysfunction (Booth et al., 2012). Continuation of exercise training may protect 
against the deterioration of health status and age-associated co-morbidities, by commencing 
the decline in bodily function from an elevated VO2peak the ageing process reflects inherent 
ageing uncompromised by inactivity (Harridge and Lazarus, 2017). From a mechanistic 
perspective, the parameters that determine VO2max (cardiac output and arterio-venous 
difference) are known to decrease with advancing age; inclusive of master athletes (Tanaka 
and Seals, 2008). The relative contribution of each parameter is unclear, though the reduction 
of VO2max observed in master endurance athletes may be due to maintenance of stroke 
volume and O2 extraction, as they do not appear to decrease by the same magnitude as heart 
rate with age (Pollock et al., 1987). Consistent with this, maximal heart rate has been shown 
to decrease at approximately 0.7 beat.min-1.year-1, and this is similar regardless of sex or 
physical activity status (Rodeheffer et al., 1984). In addition, peripheral factors influencing 
the arterio-venous difference proposed to contribute to the differences in VO2max between 
older, young, trained and control groups, include the amount of fat-free and fat mass (Tanaka 
and Seals, 2008), which have been shown to decrease and increase, respectively, with 
advancing age (Janssen et al., 2000; Kuk et al., 2009). However, the results from the present 
review demonstrated no discernible differences between groups in the amount of fat-free 
mass for master endurance athletes, age-matched untrained individuals, young untrained 
individuals and young endurance trained individuals. Wroblewski and colleagues (2011) 
demonstrated that chronic endurance exercise is able to preserve thigh muscle CSA in master 
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athletes (Wroblewski et al., 2011). From our data, it is perhaps surprising that the older 
untrained individuals did not display a marked reduction in fat-free mass with advancing age. 
However, it has previously been shown that VO2max remains lower in older trained 
individuals compared with young trained individuals, despite corrections for muscle mass 
(Proctor and Joyner, 1997). Therefore, it is more likely that reductions in capillary density, 
mitochondrial function and enzyme activity (Coggan et al., 1990) are responsible for the 
lower VO2max values observed in master endurance athlete and older controls.  
4.2. Strength 
Muscle strength and power are ~40 and ~80 % lower in older vs. younger individuals (Thom 
et al., 2007). At the top level of competition, this is reflected by decreases in sprint times, 
jumping and throwing distances (Gava et al., 2015). In terms of the general population, the 
functional significance of this decline impacts individuals’ ability to maintain ADL such as 
stair climbing, rising from a chair or opening a jar (Hairi et al., 2010). Moreover, low levels 
of muscular strength are strongly associated with an elevated risk of functional impairment 
(Cruz-Jentoft et al., 2010) and all-cause mortality (Ortega et al., 2012; Ruiz et al., 2008). The 
current meta-analyses (Figure 3) revealed that chronic endurance exercise does not prevent 
age-related declines in muscular strength. However, strength was preserved in master 
strength/power athletes to a level comparable with young untrained individuals, again 
suggesting that preservation of physical function into older age is specific to the mode of 
exercise performed.  
 
It should be noted that assessment of strength within the studies included in the meta-
analyses was achieved through a variety of methods; knee extension MVC, unilateral 
(Aagaard et al., 2007; Couppe et al., 2014; Korhonen et al., 2012; Marcell et al., 2014; 
Mikkelsen et al., 2013; Mosole et al., 2014; Pollock et al., 2015; Sipila and Suominen, 1991; 
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Sundstrup et al., 2010; Zampieri et al., 2015) and bilateral (Korhonen et al., 2006), plantar 
flexion MVC (Stenroth et al., 2016), dorsiflexion MVC (Power et al., 2010b), elbow flexion 
MVC (Power et al., 2012) and handgrip strength (Sanada et al., 2009; Suominen and Rahkila, 
1991)). In addition, the present review lacked a young strength/power trained group for 
comparison, as no studies incorporating this population met the inclusion criteria for the 
review. Therefore, we cannot draw firm conclusions on whether master strength/power 
athletes were able to maintain strength similar to that of young strength/power trained 
athletes. However, it is generally accepted that, similar to VO2max, there is an inevitable 
decline in muscle strength/power with ageing (Goodpaster et al., 2006; Rittweger et al., 
2009), evidenced longitudinally in the performance decrements of master power vs. young 
power trained athletes (Gava et al., 2015).  This suggests that the relative rate of decline in 
muscle strength is similar between trained individuals and age-matched controls. However, 
the higher absolute levels of strength provide strength-trained individuals with a much greater 
strength reserve, thus delaying the onset of impaired function and loss of independence.  
 
4.3. Muscle Mass and Morphology 
One mechanism responsible for age-related strength loss is the decline in muscle mass 
(sarcopenia) (Narici and Maffulli, 2010). In young healthy individuals, muscle mass is 
generally maintained until the 5th decade of life, after which loss of mass progresses at a rate 
of ~0.5-1% per year (Mitchell et al., 2012); and is exacerbated by protracted disuse events 
(Alkner and Tesch, 2004). Thus, by the age of 80 years an individual may have lost ~30-40% 
of peak muscle mass (Janssen et al., 2000). Due to the central role of skeletal muscle in 
physical function, basal metabolism and nutrient deposition, muscle loss can have significant 
health implications. The results from the current review suggest no age or training-related 
differences in muscle mass between groups (master endurance, older untrained, young 
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untrained and young endurance trained individuals). This may be due to a paucity of studies 
that incorporated muscle mass assessment, or that most of the included studies used 
techniques (BIA, DXA, hydrostatic weighing) with lower precision and sensitivity in cross-
sectional comparisons (MacDonald et al., 2011). The absence of any difference in muscle 
mass between groups is perhaps surprising given that the older individuals included in the 
current review were over 60 years and, therefore, beyond the age-range where sarcopenia or 
pre-sarcopenia (loss of muscle mass prior to any functional decline (Pereira et al., 2015)) may 
begin to manifest. The lack of consistency between studies highlights that further 
investigation into age and training-related differences in muscle mass is warranted.  
 
It has been shown muscle mass/volume is associated with muscular strength in young and 
older men and women (Strasser et al., 2013; Young et al., 1984), however there is a clear 
dissociation in the rate at which each declines, with strength loss progressing at a greater rate 
than muscle loss (Delmonico et al., 2009; Frontera et al., 2000).  
Concomitant with the changes in muscle mass, alterations to the neuromuscular system may 
also influence muscle force generating capacity, including reductions in the number of motor 
units, increased size and stimulation thresholds of existing motor units as a result of cyclical 
denervation and re-innervation, and increased instability of transmission at the neuromuscular 
junction (Piasecki et al., 2016b; Piasecki et al., 2015). Two studies (Mosole et al., 2014; 
Zampieri et al., 2015) identified the presence of greater numbers of denervated fibres in the 
muscles of the older controls, when compared with young and older untrained individuals. 
This lends credence to the notion that chronic exercise training, both endurance and 
resistance, is able to preserve the neural component of muscular contraction. There is 
evidence to suggest that the muscle quality (i.e., the force per unit of muscle) is more 
important than muscle mass per se and more closely associated with mortality (Newman et 
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al., 2006). Muscle quality diminishes with age due to changes in architecture (Strasser et al., 
2013), fibre type morphology (Lexell, 1995) fat and non-contractile tissue infiltration (Kent-
Braun et al., 2000), satellite cells and myonuclei (Kadi et al., 2004). Although it was not 
possible to draw firm conclusions on the impact of chronic exercise training on muscle mass 
and quality, it is clear that chronic strength/power exercise can prevent age-associated 
strength decrements. 
 
Ageing is accompanied by a reduction in the total number of muscle fibres, but more 
critically the cross-sectional area and proportion of Type II fibres (Lexell, 1995). However, 
due to the paucity of studies reporting muscle cross sectional area (Couppe et al., 2014; 
Mikkelsen et al., 2013; Rantalainen et al., 2014; Sipila and Suominen, 1991), muscle 
architecture (Korhonen et al., 2006; Ojanen et al., 2007; Sipila and Suominen, 1991) and 
fibre morphology (Aagaard et al., 2007; Cristea et al., 2008; Korhonen et al., 2006; Larsson 
et al., 1997; Mackey et al., 2014; Mosole et al., 2014; Sundstrup et al., 2010; Tarpenning et 
al., 2004a; Zampieri et al., 2015), it is challenging to elucidate their relative contribution to 
the observed loss or preservation of muscle mass and strength between master athletes and 
age-matched untrained individuals. Nevertheless, previous studies have highlighted an 
association between muscle architecture and performance (Kumagai et al., 2000), and that 
muscle architecture may differ across sporting disciplines (Abe et al., 2000). Upon further 
investigation, differences in muscle CSA, thickness and morphology may be an artefact of 
differing analytical methods (i.e. MRI, CT, ultrasound) at divergent anatomical sites (i.e. 
thigh vs. mid-tibia). Though not statistically analysed in the current review, individual studies 
have shown that master strength/power athletes maintain greater fibre cross-sectional area 
compared with untrained older individuals (Aagaard et al., 2007; Korhonen et al., 2006). In 
addition to fibre atrophy, ageing increases the intramuscular infiltration of fat and connective 
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tissue (Taaffe et al., 2009), impairing contractile properties (Lexell, 1995). Studies have 
revealed conflicting findings with respect to muscle fibre distribution between young and 
older endurance trained individuals (Mackey et al., 2014; Mosole et al., 2014; Sundstrup et 
al., 2010; Zampieri et al., 2015), which are likely underpinned by differences in the specific 
mode of exercise training and analytical methods used (Summary data for studies that 
measured these outcomes demonstrate large heterogeneity; presented in Table 3).  
 
4.4. Body Fat Mass 
Age-related alterations in body composition, specifically the increase in adiposity, likely 
contributes to impairments in muscle strength and physical function, increases dependence on 
support services and the likelihood of institutionalised care (Guralnik et al., 1996) and 
ultimately presents a significant risk factor for mortality (Kuk et al., 2006). The current meta-
analyses (Figure 2) illustrated that master endurance athletes had a significantly lower body 
fat percentage compared with age-matched controls. Body fat percentage was similar 
between master endurance, master strength/power and untrained young individuals, whereas 
young endurance trained individuals had a significantly lower body fat percentage than 
master endurance trained individuals. These data indicate that chronic exercise, endurance or 
strength/power oriented, can attenuate the increase in body fat with ageing. It has been shown 
that higher levels of physical activity are preventative for body fat mass gain (Ekelund et al., 
2011). Further, the reduction in physical activity that occurs during ageing (from retirement, 
family commitments, and a lack of other preoccupations) is a critical driver of increasing 
body fat mass (Booth et al., 2012). Unfortunately, few studies included in this review 
provided data for absolute values of fat and fat-free mass, making it difficult to draw 
conclusions about effect that chronic exercise training has on these parameters. Interestingly, 
it has previously been shown that obese individuals possess higher levels of fat-free mass 
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compared with healthy older individuals (Murton et al., 2015), suggesting a minor protective 
role of obesity against sarcopenia.  Nevertheless, we posit that muscle quality, and not 
quantity per se, plays a more important role in the maintenance of whole-body metabolic 
health (Smeuninx et al., 2017).  
 
4.5. Conclusions and Practical applications  
The aim of this systematic review and meta-analyses was to determine whether, and to what 
extent, chronic exercise preserves some of the functional and biological decrements attributed 
to ageing. This review demonstrates that chronic exercise may delay age-associated 
decrements in physical function in an exercise-mode specific manner and also protects 
against unfavourable changes in body composition.  
 
Current physical activity guidelines for older adults suggest 150 minutes per week of 
moderate-to-vigorous physical activity per week, unless chronic conditions prevent them 
doing so (American College of Sports, 2009). Guidelines also recommend that older adults 
incorporate some form resistive based exercise at least twice a week. However, the 
prevalence of functional impairment and reduced independence in older age suggests many 
older individuals are not meeting these criteria. The master athlete cohorts included in this 
review provide evidence that canonical age-related impairments in physical function, 
cardiorespiratory fitness, muscular strength and body composition can be delayed through 
chronic training, in an exercise mode-specific manner. The continuation of endurance type 
exercise to maintain high levels of cardiorespiratory fitness and strength/power training to 
preserve muscular strength offers a viable strategy to extend the health-span of older 
individuals, compressing the area under the morbidity curve and allowing maintenance of 
functional independence and good quality of life. It is apparent that few high quality studies 
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have been conducted in unique master athlete cohorts, and that further research studies 
encompassing a comprehensive selection of sophisticated measurement tools need to be 
conducted in order to fully characterise specific benefits of strength/power training and 
endurance training. Finally, the inclusion of only 268 females in this review reflects a 
preponderance of males included in the study of master athletes. This disparity warrants 
further investigation, as it has been documented that men and women may undergo somewhat 
divergent deterioration in skeletal muscle mass and strength with advancing age, perhaps due 
to reductions in sex-specific hormones (Hansen and Kjaer, 2014; Kim et al., 2016; Smith et 
al., 2008). As such, the development of sex-specific exercise training interventions, or 
manipulation of certain training variables, may be an important consideration. 
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Author, Year 
Fat-Free 
Mass 
Fat Mass Body Fat VO2max Strength 
Muscle 
Architecture 
Muscle CSA Muscle Morphology 
(Aagaard et 
al., 2007) 
- - Skinfold Cycle Ergometer Knee Extension 
MVC  (70° 
knee angle) 
- - Muscle Fibre Area, 
distribution, 
distribution by area 
(myofibrillar ATPase 
staining (Type I, IIa, 
IIx) 
(Anselme et 
al., 1994) 
- - - Cycle Ergometer 
(30W 3mins, ↑ 
30W.min-1) 
 
- - - - 
(Arbab-
Zadeh et al., 
2004) 
- - Hydrostatic 
Weighing 
Treadmill (modified 
Astrand-Saltin) 
 
- - - - 
(Ari et al., 
2004) 
- - No Details Cycle Ergometer 
(Astrand) 
 
- - - - 
 
(Bhella et al., 
2014) 
- - - Treadmill (modified 
Astrand-Saltin) 
 
- - - - 
 
(Bjork et al., 
2012) 
- - 7-Site 
Skinfold 
Treadmill (Constant 
speed, 2% ↑ grad 
every 2mins) 
- - - - 
(Buford et al., 
2010) 
 
- - DXA Treadmill - - - - 
(Buyukyazi, 
2004) 
- - 4-Site 
Skinfold 
Cycle Ergometer 
(Astrand-Ryhming 
Sub-max) 
- - - - 
(Carrick-
Ranson et al., 
2014a) 
Hydrostatic 
Weighing 
- Hydrostatic 
Weighing 
Treadmill & 
Upright cycle 
- - - - 
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Author, Year 
Fat-Free 
Mass 
Fat Mass Body Fat VO2max Strength 
Muscle 
Architecture 
Muscle CSA Muscle Morphology 
(Couppe et 
al., 2014) 
- - - Cycle Ergometer 
(50/75W start, 25W 
↑ .min-1) 
Knee Extension 
MVC (knee & 
hip angle 90°, 
10 s ramped 
contraction) 
- Anatomical 
CSA 
measured 20 
cm proximal 
to tibia 
plateau (mid-
thigh level) 
by magnetic 
resonance 
imaging 
(MRI) 
- 
(Cristea et al., 
2008) 
- - Bioelectrical 
Impedance 
- - - - Fibre area & 
distribution 
(myofibrillar ATPase 
staining (Type I, IIa, 
IIx, IIax)) 
(DubÉ et al., 
2016) 
DXA Scan DXA Scan DXA Scan Cycle Ergometer 
(50/75/10W 2mins, 
25/50W ↑ every 2 
mins) 
 
- - - - 
(Franzoni et 
al., 2005) 
 
- - - Cycle Ergometer - - - - 
 ((Galetta et 
al., 2005) 
 
- - - Cycle Ergometer - - - - 
(Galetta et al., 
2006) 
- - - Cycle Ergometer - - - - 
(Hawkins et Hydrostatic - Hydrostatic Treadmill - - - - 
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Author, Year 
Fat-Free 
Mass 
Fat Mass Body Fat VO2max Strength 
Muscle 
Architecture 
Muscle CSA Muscle Morphology 
al., 2001) 
 
Weighing Weighing (Modified Balke) 
 
(Hayes et al., 
2015) 
 
Bioelectrical 
Impedance 
- Bioelectrical 
Impedance 
Cycle Ergometer 
(Ramp) 
- - - - 
(Katzel et al., 
1998) 
 
- - Hydrostatic 
Weighing 
Treadmill 
(Modified Balke) 
- - - - 
(Katzel et al., 
2001) 
 
- - - Treadmill 
(Modified Balke) 
-  - - 
(Korhonen et 
al., 2006) 
- - Bioelectrical 
Impedance 
- Bilateral 
Isometric MVC 
(107° knee & 
110° hip angle) 
Muscle 
thickness & 
pennation angle 
(50% Vastus 
lateralis) 
- Fibre area & 
distribution 
(myofibrillar ATPase 
staining (Type I, IIa, 
IIx, IIax)) 
(Korhonen et 
al., 2012) 
- - Bioelectrical 
Impedance 
- Unilateral 
Isometric MVC 
(90° knee & 
110° hip angle) 
- - - 
(Larsson et 
al., 1997) 
- - - - - - - Fibre distribution 
(myofibrillar ATPase 
staining (Type I, IIa, 
IIx, IIax)) 
 
(Mackey et 
al., 2014) 
- - - Cycle Ergometer - - - Fibre Area & 
distribution 
(primary/secondary 
antibodies (Type I & 
II)) 
(Marcell et Hydrostatic  Hydrostatic Treadmill - - - - 
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Author, Year 
Fat-Free 
Mass 
Fat Mass Body Fat VO2max Strength 
Muscle 
Architecture 
Muscle CSA Muscle Morphology 
al., 2003) 
 
Weighing Weighing (Modified Balke) 
(Marcell et 
al., 2014) 
Hydrostatic 
Weighing 
- Hydrostatic 
Weighing 
Treadmill 
(Modified Balke) 
Unilateral 
Isometric MVC  
(60° knee 
flexion) 
- - - 
(Matelot et 
al., 2016) 
 
- - No Details Cycle Ergometer - - - - 
(Mikkelsen et 
al., 2013) 
- -  
- 
Cycle Ergometer 
(50/75W start, ↑ 
25W.min-1) 
Knee Extension 
MVC (knee & 
hip angle 90°, 
10 s ramped 
contraction) 
- Anatomical 
CSA 
measured 20 
cm proximal 
to tibia 
plateau (mid-
thigh level) 
by magnetic 
resonance 
imaging 
(MRI) 
- 
(Molmen et 
al., 2012) 
 
- - - Treadmill (Gradient 
10% with ↑ speed 
every min) 
 
- - - - 
(Mortensen et 
al., 2012) 
 
- - No Details Cycle Ergometer  - - - 
(Mosole et al., 
2014) 
- - - - Knee Extension 
MVC 
(Relative) 
- - Fibre distribution 
(H+E & primary 
secondary antibodies 
(type I, II, co-
expressing, 
denervated)) 
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Author, Year 
Fat-Free 
Mass 
Fat Mass Body Fat VO2max Strength 
Muscle 
Architecture 
Muscle CSA Muscle Morphology 
 
(Mucci et al., 
1999) 
 
- - - Cycle Ergometer 
(30W 3mins, 
↑30W.min-1) 
- - - - 
(Nyberg et al., 
2012) 
- - No Details Cycle Ergometer - - - - 
(Ojanen et al., 
2007) 
- - 4-Site 
Skinfold / 
Bioelectrical 
Impedance 
- - Muscle 
thickness 
(Vastus 
lateralis + 
Vastus 
intermedius, 
lower 1/3 
between greater 
trochanter & 
lateral joint line 
of knee) 
- - 
(Pollock et al., 
2015) 
DXA Scan - DXA Scan Cycle Ergometer 
(50W 3mins, ↑ 1-
2W every 3-5s) 
Knee Extension 
MVC (90° 
Knee angle) 
- - - 
(Power et al., 
2012) 
- - - -  
Bicep Brachii 
MVC (110° 
Elbow flexion) 
- - - 
(Power et al., 
2010a) 
- - - -  
Tibialis 
Anterior MVC 
- - - 
(Prasad et al., 
2007) 
 
- - - No details - - - - 
(Prefaut et 
al., 1994) 
- - - Cycle Ergometer 
(30W 3mins, ↑ 
30W.min-1) 
- - - - 
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Author, Year 
Fat-Free 
Mass 
Fat Mass Body Fat VO2max Strength 
Muscle 
Architecture 
Muscle CSA Muscle Morphology 
 
 
(Proctor and 
Joyner, 1997) 
 
 
DXA Scan - DXA Scan Treadmill (2% ↑ 
grad every other 
min) 
- - - - 
(Rantalainen 
et al., 2014) 
- - - - - - Peripheral 
quantitative 
computed 
tomography 
(p-QCT) 
- 
(Rivier et al., 
1994) 
- - - Cycle Ergometer 
(30W 3mins, ↑ 
30W.min-1) 
- - - - 
 
(Sallinen et 
al., 2008) 
 
  4-Site 
Skinfold 
- - - - - 
(Sanada et al., 
2009) 
DXA Scan - DXA Scan Cycle Ergometer 
(90W, ↑ 30W.min-1) 
Rowing Ergometer 
100W start, 50W ↑ 
.min-1) 
 
Handheld 
dynamometer 
- - - 
(Schmidt et 
al., 2015) 
- DXA Scan DXA Scan Cycle Ergometer 
(40W start, ↑ 20W 
every 2 mins) 
- - - - 
 
(Shibata and 
Levine, 2012) 
 
- - - No details -   - 
(Sipila and - - - - Knee extension Muscle Ultrasound - 
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Author, Year 
Fat-Free 
Mass 
Fat Mass Body Fat VO2max Strength 
Muscle 
Architecture 
Muscle CSA Muscle Morphology 
Suominen, 
1991) 
MVC (60° 
Knee angle) 
thickness (no 
details on site 
of 
measurement) 
Scanning 
(midpoint 
between 
greater 
trochanter 
and knee 
joint line) 
(Stenroth et 
al., 2016) 
- - - - Plantar Flexion 
MVC (ankle 
90°, knee full 
extended, hip 
60° angle) 
- - - 
(Sundstrup et 
al., 2010) 
- - - No details Knee Extension 
MVC  (70° 
Knee angle) 
- - Fibre area,  
distribution, 
distribution by area 
(myofibrillar ATPase 
staining (Type I, IIa, 
IIx, IIax)) 
(Suominen 
and Rahkila, 
1991) 
- - - Cycle Ergometer 
(90W start, ↑30W 
every 2 mins) 
Handheld 
dynamometer 
- - - 
(Tarpenning 
et al., 2004b) 
Hydrostatic 
Weighing 
- Hydrostatic 
Weighing 
Treadmill (2.5mph 
start, ↑0.5mph and 
2% grade every 2 
mins) 
 
- - - Fibre area & 
distribution 
(myofibrillar ATPase 
staining (Type I & II)) 
(Thomas et 
al., 2013) 
- - -  
Treadmill (modified 
Astrand-Saltin) 
 
- - - - 
(Trappe et al., 
2013) 
DXA Scan - DXA Scan Cycle Ergometer 
(Trained: 50W start 
↑15W.min-1, 20W 
- - - - 
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Author, Year 
Fat-Free 
Mass 
Fat Mass Body Fat VO2max Strength 
Muscle 
Architecture 
Muscle CSA Muscle Morphology 
start ↑10w.min-1) 
(Witkowski et 
al., 2010) 
 
- - DXA Scan Cycle Ergometer 
(50W start 
↑15W.min-1) 
- - - - 
 
(Yataco et al., 
1997) 
 
Hydrostatic 
Weighing 
Hydrostatic 
Weighing 
Hydrostatic 
Weighing 
Treadmill 
(Modified Balke) 
- - - - 
(Zampieri et 
al., 2015) 
- - - - Knee extension 
MVC 
- - Fibre diameter & 
distribution (H + E, 
myofibrillar ATPase 
staining (Type I & II)) 
Table 1) Included studies and associated measures. DXA, Dual energy x-ray absorptiometry; H + E, Hematoxylin and eosin; MVC, maximal voluntary 
contraction; W, Watts.  
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
(Aagaard et al., 
2007) 
Older Control 8 M 70.5 
(2.8) 
1.75 
(0.06) 
82.9 
(6.2) 
27.1 - - 
Master Endurance 
Athlete 
9 M 71.9 
(4.3) 
1.74 
(0.07) 
76.0 
(8.3) 
25.2 >50 Running/Cycling 
Master power 
athletes 
7 M 73.9 
(2.2) 
1.75 
(0.04) 
78.7 
(20.1) 
25.7 >50 Sprinting/Shotput/hig
h- and long-jump 
(Anselme et al., 
1994) 
Young Endurance 7 M 22.2 
(3.3) 
1.80 
(0.05) 
68.6 
(2.9) 
21.3 5 (3.7) Triathletes 
Master Endurance 
Athlete 
7 M 66.2 
(7.8) 
1.69 
(0.06) 
75.4 
(5.9) 
26.5 30 (13.2) Cyclists 
Young Control 7 M 23.4 
(5.2) 
1.75 
(0.06) 
67.2 
(12.0) 
22.0 - Habitually active 
Older Control 7 M 67.6 
(7.3) 
1.67 
(0.04) 
67.6 
(2.8) 
24.1 - Habitually active 
(Arbab-Zadeh et 
al., 2004) 
Older Control 12 M=6 
F=6 
69.8 
(3.0) 
1.68 
(0.10) 
73.3 
(10.6) 
25.9 - - 
Young Control 14 M=7 
F=7 
28.9 
(5.0) 
1.74 
(0.06) 
71.2 
(4.4) 
23.6 - - 
Master Endurance 
Athlete 
12 M=6 
F=6 
67.8 
(3.0) 
1.70 
(0.11) 
64.6 
(13.5) 
22.4 23 (8) Running/Cycling/ 
Swimming 
(Ari et al., 2004) Master Endurance 
Athlete 
10 M 68.0 
(6.0) 
1.67 
(0.08) 
71.0 
(3.0) 
25.5 41 (8) Aerobic 
Older Control 11 M 65.0 
(5.0) 
1.69 
(0.05) 
81.0 
(11.0) 
28.4 - - 
(Bhella et al., 
2014) 
Older Control 27 M=15 
F=12 
68.8 
(5.1) 
1.70 
(0.10) 
74.7 
(11.2) 
26.0 - - 
Master Endurance 
Athlete 
25 M=17 
F=8 
67.8 
(2.9) 
1.71 
(0.10) 
65.6 
(12.1) 
22.4 25 Running/Cycling/ 
Swimming 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
(Bjork et al., 
2012) 
Young Endurance 7 M 25.0 
(5.3) 
1.83 
(0.26) 
81.1 
(12.7) 
24.4 >3 Moderate-high 
intensity 
Young Control 8 M 25  
(2.8) 
1.81 
(0.28) 
77.9 
(19.0) 
23.6 - - 
Master Endurance 
Athlete 
12 M 62  
(6.9) 
1.76 
(0.35) 
70.7 
(10.4) 
22.9 >30 Moderate-high 
intensity 
Older Control 11 M 64  
(6.6) 
1.75 
(0.33) 
74.7 
(8.0) 
24.3 - - 
(Buford et al., 
2010) 
Young Control 14 M 21.4 
(3.8) 
1.77 
(0.06) 
79.6 
(17.1) 
25.4 - - 
Older Control 13 M 63.9 
(6.6) 
1.74 
(0.06) 
93.7 
(15.3) 
30.9 - - 
Master Endurance 
Athlete 
14 M 60.7 
(5.5) 
1.76 
(0.05) 
84.2 
(7.2) 
27.1 23.08 (12.6) Running/Jogging/Bas
ketball/ Resistance 
(Buyukyazi, 2004) Master Endurance 
Athlete 
11 M 67.1 
(6.0) 
1.67 
(0.08) 
70.9 
(3.2) 
25.5 38.8 (18.5) Middle/Long-distance 
Runners 
Older Control 11 M 64.9 
(4.6) 
1.69 
(0.06) 
81.6 
(11.4) 
28.3 - - 
(Carrick-Ranson 
et al., 2014a) 
Older Control 27 M=15 
F=12 
69  
(5.0) 
1.69 
(0.10) 
75.0 
(11.0) 
26.3 - - 
Master Endurance 
Athlete 
25 M=17 
F=8 
68  
(3.0) 
1.71 
(0.10) 
66.0 
(12.0) 
22.6 25 Running/Cycling/ 
Swimming 
(Couppe et al., 
2014) 
Young Endurance 10 M 26.0 
(4.0) 
1.79 
(0.04) 
73.0 
(6.0) 
23.0 6 (3.16) Endurance running 
Young Control 12 M 24.0 
(3.0) 
1.78 
(0.06) 
70.0 
(8.0) 
22.0 - - 
Master Endurance 
Athlete 
15 M 64.0 
(4.0) 
1.76 
(0.05) 
71.0 
(6.0) 
23.0 28 (7.75) Endurance running 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
Older Control 12 M 66.0 
(4.0) 
1.75 
(0.04) 
75.0 
(4.0) 
25.0 - - 
(Cristea et al., 
2008) 
Master power 
athletes 
7 M 66.0 
(7.9) 
1.73 
(0.05) 
71.3 
(6.6) 
23.8 32 (18.5) Sprint/Strength 
Master power 
athletes 
4 M 71.0 
(10.0) 
1.71 
(0.04) 
69.6 
(7.2) 
23.8 24 (8) Sprint Strength 
(DubÉ et al., 
2016) 
Young Endurance 14 M=7  
F=7 
27.8 
(4.9) 
- 65.7 
(10.8) 
22.12 5-13 Non-competitive 
recreational exercise 
Master Endurance 
Athlete 
13 M=9  
F=4 
64.8 
(4.9) 
- 68.2 
(10.0) 
23.76 35-40 Running, Cycling, 
Swimming, or 
Aerobic dancing 
(Franzoni et al., 
2005) 
Young Control 16 M 34.1 
(7.5) 
- - 23.1 - - 
Older Control 16 M 63.7 
(4.3) 
- - 24.2 - - 
Young Endurance 16 M 33.4 
(6.7) 
- - 23.4 11 (2) Endurance Running 
Master Endurance 
Athlete 
16 M 63.6 
(6.1) 
- - 23.9 37 (5) Endurance Running 
(Galetta et al., 
2005) 
Master Endurance 
Athlete 
20 M 68.5 
(4.5) 
- - 23.4 >40 Endurance Running 
Older Control 20 M 68.2 
(3.7) 
- - 24.1 - - 
(Galetta et al., 
2006) 
Older Control 28 M 65.6 
(5.6) 
5.60 - - - - 
Master Endurance 
Athlete 
30 M 64.5 
(4.5) 
4.50 - - >40 Endurance Running 
(Hawkins et al., Master Endurance 34 M 62.2 1.77 77.0 24.5 22.6 (9.3) Endurance Running 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
2001) Athlete (3.5) (0.02) (7.6) 
Master Endurance 
Athlete 
13 M 71.1 
(3.2) 
1.73 
(0.03) 
67.5 
(9.4) 
22.7 21.6 (11.5) Endurance Running 
Master Endurance 
Athlete 
8 M 82.8 
(4.0) 
1.73 
(0.02) 
68.9 
(5.9) 
23.0 25.9 (22.3) Endurance Running 
(Hayes et al., 
2015) 
Older Control 28 M 63.0 
(5.0) 
1.75 
(0.06) 
90.4 
(18.1) 
29.5 - - 
Master Endurance 
Athlete 
20 M 60.0 
(5.0) 
1.74 
(0.06) 
79.3 
(13.3) 
26.2 >30 Water-
polo/Triathlon/Sprint 
cycling/Road 
cycling/Distance 
running 
(Katzel et al., 
1998) 
Master Endurance 
Athlete 
70 M 63.0 
(6.0) 
- 70.0 
(8.0) 
23.0 >20 Running/Triathlon/Cy
cling/ Tennis 
Older Control 85 M 61.0 
(7.0) 
- 83.0 
(11.0) 
27.0 -  
(Katzel et al., 
2001) 
Master Endurance 
Athlete 
42 M 63.4 
(6.5) 
 69.4 
(7.8) 
23.1 >20 Running/Triathlon/Cy
cling/ Tennis 
Older Control 47 M 61.1 
(6.2) 
 91.4 
(11.7) 
29.3 - - 
(Korhonen et al., 
2006) 
Young Power 16 M 24.3 
(4.0) 
1.78 
(0.04) 
77.2 
(5.6) 
24.4 13.2 (5.2) Sprint/Strength 
Master power 
athletes 
21 M 65.8 
(2.8) 
1.73 
(0.04) 
77.2 
(4.1) 
25.9 35.1 (19.3) Sprint/Strength 
Master power 
athletes 
20 M 75.3 
(4.0) 
1.71 
(0.05) 
69.8 
(8.9) 
23.8 34.3 (21.9) Sprint/Strength 
(Korhonen et al., 
2012) 
Young Control 19 M 36.2 
(4.4) 
1.82 
(0.06) 
79.2 
(6.8) 
24.0 - Ball 
games/Jogging/Cross-
country skiing 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
Master power 
athletes 
24 M 65.9 
(2.6) 
1.72 
(0.04) 
71.1 
(5.6) 
24.0 35.1 (18.4) Sprint/Strength 
Master power 
athletes 
24 M 75.8 
(4.3) 
1.71 
(0.06) 
70.3 
(8.5) 
24.1 34.3 (21.4) Sprint/Strength 
(Larsson et al., 
1997) 
Young control 4 M 25-31 - - - - - 
Older Control 2 M 73-81 - - - - - 
Master Endurance 
Athlete 
2 M 73-81 - - - >50 Endurance Trained/ 
Competitive Wrestler 
(Mackey et al., 
2014) 
Young Control 12 M 24.0 
(3.0) 
1.78 
(0.06) 
70.0 
(8.0) 
22.2 - - 
Young Endurance 10 M 26.0 
(4.0) 
1.79 
(0.04) 
73.0 
(6.0) 
22.7 6.0 (2.0) Endurance Running 
Older Control 12 M 66.0 
(4.0) 
1.75 
(0.04) 
75.0 
(4.0) 
24.5 - - 
Master Endurance 
Athlete 
15 M 64.0 
(4.0) 
1.76 
(0.05) 
71.0 
(6.0) 
22.9 28.0 (9.0) Endurance Running 
(Marcell et al., 
2003) 
 
Master Endurance 
Athlete 
9 M 67.1 
(1.2) 
 70.2 
(4.8) 
23.2 23.6 (12.6) Endurance Running 
(Marcell et al., 
2014) 
 
Master Endurance 
Athlete 
21 M 71.3 1.74 71.3 23.5 24.9 Endurance Running 
(Matelot et al., 
2016) 
 
Master Endurance 
Athlete 
13 M 62.0 
(3.0) 
1.72 
(0.04) 
71.2 
(6.1) 
24.1 39.0 (4.0) Endurance 
Running/Cycling 
(Mikkelsen et al., 
2013) 
Young Control 12 M 24.0 
(3.0) 
1.78 
(0.06) 
70.0 
(8.0) 
22.0 - - 
Young Endurance 10 M 26.0 1.79 73.0 23.0 6.0 (3.16) Endurance Running 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
(4.0) (0.04) (6.0) 
Older Control 12 M 66.0 
(4.0) 
1.75 
(0.04) 
75.0 
(4.0) 
25.0 - - 
Master Endurance 
Athlete 
15 M 64.0 
(4.0) 
1.76 
(0.04) 
71.0 
(6.0) 
23.0 28.0 (7.75) Endurance Running 
(Molmen et al., 
2012) 
Older Control 10 M 71.7 
(1.3) 
 76.5 
(9.4) 
25.0   
Young Control 10 M 24.8 
(2.3) 
 76.0 
(16.0) 
22.7   
Master Endurance 
Athlete 
11 M 74.3 
(1.8) 
 74.5 
(8.3) 
23.0 >25 Cross Country Skiers 
(Mortensen et al., 
2012) 
Young Control 8 M 23.0 
(2.8) 
1.83 
(0.01) 
79.0 
(11.3) 
23.6 - - 
Older Control 8 M 66.0 
(5.7) 
1.75 
(0.01) 
79.0 
(5.7) 
25.8 - - 
Master Endurance 
Athlete 
8 M 62.0 
(5.7) 
1.78 
(0.01) 
76.0 
(8.5) 
24.0 >30 Endurance trained 
(Mosole et al., 
2014) 
Young Power 5 M 26.2 
(4.0) 
- - - >5.0 Weightlifting 
Older Control 6 M=4  
F=2 
71.8 
(3.5) 
- - - - - 
Master Endurance 
Athlete 
7 M 68.3 
(4.0) 
- - - >20 Endurance/Mixed 
(Mucci et al., 
1999) 
Young Athletes 7 M 26.1 
(3.4) 
1.78 
(0.10) 
67.8 
(7.7) 
21.4 4.0 (2.38) Triathlon/Endurance 
Running 
Young Control 7 M 23.0 
(4.0) 
1.83 
(0.09) 
73.3 
(10.1) 
21.9 - - 
Master Endurance 7 M 64.4 1.69 72.3 25.4 25 (5.29) Cycling 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
Athlete (10.9) (0.13) (11.1) 
Older Control 7 M 61.6 
(3.4) 
1.69 
(0.04) 
69.6 
(4.2) 
24.4 - - 
(Nyberg et al., 
2012) 
Young Control 8 M 23.0 
(2.8) 
1.83 
(0.06) 
79.4 
(12.2) 
23.7 - - 
Older Control 8 M 66.0 
(5.7) 
1.75 
(0.08) 
79.2 
(5.1) 
25.9 - - 
Master Endurance 
Athlete 
8 M 62.0 
(5.7) 
1.78 
(0.06) 
75.7 
(8.8) 
23.9 >30 Endurance trained 
(Ojanen et al., 
2007) 
Master power 
athletes 
12 M 60.8 
(2.1) 
1.78 
(0.08) 
94.2 
(13.4) 
29.8 27.5 (14.8) Shotput / Discus / 
Hammer 
Master power 
athletes 
9 M 75.0 
(4.9) 
1.77 
(0.05) 
87.4 
(11.0) 
27.8 27.2 (19.8) Shotput / Discus / 
Hammer 
Older Control 10 M 61.1 
(2.7) 
1.77 
(0.06) 
80.0 
(12.2) 
25.5 - - 
Older Control 5 M 69.2 
(3.7) 
1.75 
(0.06) 
75.7 
(11.1) 
24.7 - - 
(Pollock et al., 
2015) 
Master Endurance 
Athlete 
24 M 62.0 
(1.4) 
1.70 
(0.06) 
76.8 
(8.5) 
24.7 27.6 (17.5) Cycling 
Master Endurance 
Athlete 
19 M 67.0 
(1.2) 
1.77 
(0.06) 
72.6 
(7.2) 
23.2 26.5 (19.6) Cycling 
Master Endurance 
Athlete 
19 M 73.4 
(2.6) 
1.76 
(0.06) 
74.4 
(10.1) 
24.1 36.7 (19.5) Cycling 
Master Endurance 
Athlete 
15 F 61.9 
(1.6) 
1.66 
(0.06) 
60.4 
(5.5) 
22.1 24.6 (20.3) Cycling 
Master Endurance 
Athlete 
4 F 75.3 
(3.0) 
1.61 
(0.07) 
57.1 
(6.4) 
22.0 45 (19.6) Cycling 
(Power et al., Young Control 9 M 27.0 1.81 80.8 24.6 - - 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
2012) (5.0) (0.07) (9.6) 
Older Control 9 M 70.0 
(5.0) 
1.78 
(0.07) 
90.1 
(17.4) 
28.5 - - 
Master Endurance 
Athlete 
9 M = 8  
F = 1 
67.0 
(4.0) 
1.74 
(0.06) 
71.3 
(10.5) 
23.5 >30 Endurance Running 
(Power et al., 
2010a) 
Young Control 10 M 27.0 
(3.0) 
1.78 
(0.08) 
80.7 
(10.0) 
25.6 - - 
Older Control 10 M 66.0 
(3.0) 
1.72 
(0.07) 
78.8 
(10.4) 
26.7 - - 
Master Endurance 
Athlete 
10 M = 9  
F = 1 
64.0 
(3.0) 
1.77 
(0.07) 
72.3 
(7.7) 
23.0 38.2 (6.7) Endurance Running 
(Prasad et al., 
2007) 
Young Control 12 M = 9  
F = 3 
32.3 
(9.0) 
- - - - - 
Older Control 13 M= 7  
F = 6 
69.8 
(3.0) 
- - - - - 
Master Endurance 
Athlete 
12 M = 6  
F = 6 
67.8 
(3.0) 
- - - 23.0 (8.0) Marathons, 
Triathlons, Middle 
distance 
(Prefaut et al., 
1994) 
Master Endurance 
Athlete 
10 M 65.3 
(8.2) 
1.68 
(0.07) 
70.1 
(4.3) 
24.8 33.0 (18.0) Cycling 
Older Control 10 M 68.3 
(7.0) 
1.72 
(0.05) 
74.8 
(7.6) 
25.3 - - 
Young Endurance 10 M 23.3 
(3.5) 
1.80 
(0.03) 
68.8 
(6.0) 
21.2 - - 
(Proctor and 
Joyner, 1997) 
Young Endurance 8 M 24.0 
(4.0) 
1.80 
(0.07) 
70.9 
(7.8) 
21.9 9.0 (3.0) Running, Cycling, 
Triathlon 
Running, Cycling, 
Triathlon 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
Running, Cycling, 
Triathlon 
Master Endurance 
Athlete 
8 M 64.0 
(4.0) 
1.78 
(0.06) 
75.5 
(10.2) 
23.8 21.0 (5.0)  
Young Endurance 8 F 26.0 
(4.0) 
1.71 
(0.05) 
60.1 
(5.5) 
20.6 9.0 (5.0)  
(Rantalainen et 
al., 2014) 
Young Power 26 M 27.4 
(5.1) 
1.81 
(0.05) 
76.7 
(5.9) 
23.4 15.4 (6.2) Sprinting 
Young Control 41 M 28.7 
(5.8) 
1.8 
(0.06) 
78.1 
(9.6) 
24.1 - - 
Master power 
athletes 
35 M 72.4 
(5.3) 
1.71 
(0.05) 
70.7 
(7.1) 
24.2 35.4 (19.1) Sprinting 
Older Control 24 M 71.6 
(4.2) 
1.71 
(0.06) 
75.8 
(8.6) 
25.9 - - 
(Rivier et al., 
1994) 
Young Endurance 10 M 23.9 
(3.6) 
1.78 
(0.05) 
69.4 
(5.8) 
21.8 - Triathlon 
Master Endurance 
Athlete 
6 M 63.7 
(5.0) 
1.67 
(0.06) 
75.3 
(4.0) 
27.0 30.0 (5.0) Cycling 
(Sallinen et al., 
2008) 
Young Control 10 M 25.7 
(3.4) 
1.82 
(0.04) 
77.0 
(5.2) 
23.3 - - 
Master power 
athletes 
8 M 71.8 
(3.8) 
1.75 
(0.06) 
86.3 
(10.7) 
28.4 22.8 (14.9) National level 
throwers 
Older Control 10 M 70.6 
(3.3) 
1.70 
(0.06) 
71.4 
(71.4) 
24.7 - - 
(Sanada et al., 
2009) 
Young Control 23 M 25.3 
(2.7) 
- 70.8 
(11.2) 
23.5 - - 
Older Control 22 M 65.2 
(4.1) 
- 69.7 
(8.1) 
24.3 - - 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
Young Endurance 26 M 20.3 
(1.0) 
- 69.3 
(5.7) 
22.3 3.0 Rowing 
Master Endurance 
Athlete 
24 M 65.7 
(3.0) 
- 67.9 
(8.2) 
23.0 46.7 (2.8) Rowing 
(Schmidt et al., 
2015) 
Master Endurance 
Athlete 
17 M 68.1 
(2.1) 
1.78 
(0.03) 
78.1 
(8.2) 
24.6 52.0 (11.0) Football 
Older Control 26 M 68.2 
(3.2) 
1.76 
(0.03) 
84.1 
(11.1) 
27.2 - - 
(Shibata and 
Levine, 2012) 
Older Control 10 M = 6  
F = 4 
71.0 
(3.0) 
1.71 
(0.09) 
74.0 
(10.0) 
26 - - 
Master Endurance 
Athlete 
11 M = 5  
F = 6 
68.0 
(3.0) 
1.70 
(0.12) 
65.0 
(14.0) 
22.1 23.0 (8.0) Endurance Running 
(Sipila and 
Suominen, 1991) 
Master power 
athletes 
7 M 77.1 
(3.5) 
1.69 
(0.06) 
69.8 
(9.3) 
- 30 to 70 Track and field, 
Gymnastics 
Master Endurance 
Athlete 
14 M 74.2 
(3.0) 
1.71 
(0.07) 
68.7 
(8.6) 
- 30 to 70 Running, Cross-
country Skiing, 
Cycling, Swimming 
Older Control 11 M 73.4 
(2.4) 
1.68 
(0.04) 
74.7 
(11.6) 
- - - 
(Stenroth et al., 
2016) 
Young Control 18 M 23.7 
(2.0) 
1.81 
(0.06) 
75.4 
(9.0) 
23.1 - - 
Older Control 33 M 74.8 
(3.6) 
1.73 
(0.05) 
76.1 
(7.7) 
25.4 - - 
Master Endurance 
Athlete 
10 M 74.0 
(2.8) 
1.75 
(0.07) 
69.9 
(6.9) 
22.7 39.4 (20.9) Endurance Exercise 
Older Power 10 M 74.4 
(2.8) 
1.76 
(0.07) 
74.3  
(7.1) 
24.1 44.7 (19.7) Sprinting 
(Sundstrup et al., Master Endurance 10 M 69.6 1.77 83.7 26.8 50.0 Football 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
2010) Athlete (4.4) (0.05) (8.9) 
Young Control 49 M 32.4 
(6.3) 
1.82 
(0.05) 
87.7 
(12.6) 
26.5 - - 
Older Control 8 M 70.5 
(2.8) 
1.75 
(0.06) 
82.9 
(6.2) 
27.1 - - 
(Suominen and 
Rahkila, 1991) 
Master Endurance 
Athlete 
67 M 73.7 
(2.7) 
1.71 
(0.07) 
69.3 
(8.6) 
23.8 - Endurance Running, 
Orienteers, Cross-
country Skiers 
Master power 
athletes 
14 M 74.3 
(2.9) 
1.74 
(0.06) 
82.4 
(12.5) 
27.1 - Throwers, Weight 
Lifters 
Master power 
athletes 
16 M 75.5 
(3.8) 
1.70 
(0.06) 
69.4 
(12.0) 
24.1 - Sprinters, Jumpers 
Older Control 42 M 74.2 
(2.8) 
1.69 
(0.07) 
76.3 
(12.0) 
26.7 -  
(Tarpenning et al., 
2004b) 
Master Endurance 
Athlete 
29 M 64.2 
(2.3) 
1.76 
(0.07) 
71.5 
(8.1) 
23.1 20.33 (9.0) Endurance Running 
Master Endurance 
Athlete 
11 M 74.6 
(3.5) 
1.74 
(0.06) 
68.6 
(7.0) 
22.6 24 (20.6) Endurance Running 
(Thomas et al., 
2013) 
Master Endurance 
Athlete 
10 M = 7  
F = 3 
74.5 
(5.8) 
- - - 23.0 (8.0) Endurance Running, 
Swimming, Cycling 
Older Control 10 M = 8  
F = 2 
75.4 
(5.6) 
- - - - - 
Young Control 9 M = 5  
F = 4 
27.0 
(3.6) 
- - - - - 
(Trappe et al., 
2013) 
Master Endurance 
Athlete 
9 M 81.0 
(3.0) 
1.72 
(0.06) 
68.0 
(9.0) 
23.0 >50 Cross-country Skiing, 
Orienteering, Track 
and Field 
 Older Control 6 M 82.0 1.72 77.0 26.0 - - 
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Author, Year Participant 
Groups 
Number 
(n) 
Sex 
(M/F) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
BMI 
(Kg.m2) 
Training 
Experience 
(years) 
Type of Training 
(4.9) (0.10) (12.2) 
(Witkowski et al., 
2010) 
Older Control 11 M 64.0 
(6.6) 
1.76 
(0.07) 
73.0 
(8.0) 
23.6 - - 
Master Endurance 
Athlete 
12 M 62.0 
(6.9) 
1.78 
(0.10) 
70.1 
(10.0) 
22.0 32.0 (10.4) Endurance Training 
(Yataco et al., 
1997) 
Master Endurance 
Athlete 
61 M 63.3 
(6.1) 
- 70.1 
(7.1) 
22.9 >20 Running/Cycling/ 
Swimming 
Older Control 39 M 60.6 
(5.6) 
- 77.1 
(8.5) 
25.6   
(Zampieri et al., 
2015) 
Young Control 5 M 27.3 
(4.2) 
1.75 
(0.04) 
73.8 
(5.9) 
24.2 - - 
 Older Control 9 M 71.4 
(3.0) 
1.77 
(0.08) 
84.9 
(10.1) 
26.9 - - 
 Master Endurance 
Athlete 
15 M 70.2 
(4.0) 
1.76 
(0.05) 
81.7 
(8.8) 
26.3 >30 Endurance, Strength, 
Power and Games 
Table 2) Anthropometric characteristics and training background of study groups (mean ± SD) included in this review, (e.g. n, age, height, weight, BMI, years 
of training, and type of training undertaken).   
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Study Group Fat-Free 
Mass 
(kg) 
Fat 
Mass 
(kg) 
Body 
Fat 
(%) 
Muscle 
Thickness 
(cm) 
Fascicle 
Length 
(cm) 
Muscle Cross-
Sectional Area 
(mm2) 
Muscle Fibre 
Area 
(µm2) 
Muscle Fibre 
Distribution (%) 
Young 
Controls 
53.8 ± 5.7 
(1, n=23) 
- 17.4 ± 
3.0 
(8, 
n=126) 
- - MRI: 6792 ± 696 
(n=12) 
Type I: 4282 ± 
26 (2, n=28), 
Type 2: 4783 ± 
872 (1, n=12) 
Type IIa: 4700 ± 
560.0 (1, n=16) 
Type IIx: 3200 ± 
2720 (1, n=16) 
Type IIax: 3700 
± 760 (1, n=16) 
Type I: 43.5 ± 4.5 
(4, n=37) 
Type 2: 53.5 ± 5.0 
(2, n=17) 
Type IIa: 35 ± 12 
(1, n=16) 
Type IIx: 7.5 ± 6.4 
(2, n=20) 
Type IIax: 12.0 ± 
00 (2, n=20) 
Denervated: (0.3 ± 
0.0 (1, n=5) 
Young 
Endurance 
54.8 ± 7.3 
(4, n=56) 
12.0 ± 
4.2 
(1, 
n=14) 
14.8 ± 
4.9 
(8, 
n=89) 
- - MRI: 7859 ± 636 
(n=10) 
Type I: 5550 ± 
1337 (1, n=10) 
Type 2: 5498 ± 
1559 (1, n=10) 
 
Type I: 51.5 ± 13.4 
(2, n=15) 
Type 2: 48.6 ± 
13.5 (2, n=15) 
Type IIax: 0.5 ± 
0.6 (1, n=5) 
Denervated: 0.4 ± 
0.5 (1, n=5) 
Young Power - - - VL: 2.61 ± 0.08 
(n=16) 
VL: 7.91 ± 0.49 
(n=16) 
- - - 
Older 
Controls 
54.5 ± 7.7 
(5, n=122) 
20.1 ± 
6.3 
(2, 
n=65) 
24.5 ± 
4.6 
(20, 
n=368) 
RF: 2.8 ± 0.56 
(n=11) 
- MRI: 5504 ± 727 
(n=12) 
US: 4840 ±1110 
(n=11) 
Type I: 5488 ± 
459 (3, n=28) 
Type 2: 4149 ± 
903 (1, n=12) 
Type IIa: 5411 ± 
484 (2, n=16) 
Type IIx: 3974 ± 
0 (2, n=16) 
Type IIax: 4570 
Type I: 49.8 ± 4.2 
(6, n=45) 
Type 2: 50.3 ± 4.0 
(3, n=27) 
Type IIa: 23.5 ± 0 
(2, n=16) 
Type IIx: 22.2 ± 
13.1 (3, n=18) 
Type IIax: 5.9 ± 
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Study Group Fat-Free 
Mass 
(kg) 
Fat 
Mass 
(kg) 
Body 
Fat 
(%) 
Muscle 
Thickness 
(cm) 
Fascicle 
Length 
(cm) 
Muscle Cross-
Sectional Area 
(mm2) 
Muscle Fibre 
Area 
(µm2) 
Muscle Fibre 
Distribution (%) 
± 980 (1, n=4) 5.8 (2, n=8) 
Denervated: 5.3 ± 
1.8 (2, n=15) 
Master 
Endurance 
55.2 ± 6.1 
(19, n=366) 
14.1 ± 
3.6 
(3, 
n=91) 
19.2 ± 
4.1 
(38, 
n=595) 
RF: 2.77 ± 0.39 
(n=14) 
- MRI: 6481 ±775 
(n=15) 
US: 5270 ± 880 
(n=14) 
Type I: 5367 ± 
588 (5, n=74) 
Type 2: 4478 ± 
347 (3, n=55) 
Type IIa: 5043 ± 
41 (2, n=19) 
Type IIx: 3955 ± 
88 (2, n=19) 
Type IIax: 3590 
± 687 (1, n=7) 
Type I: 60.8 ± 10.7 
(7, n=96) 
Type 2: 38.4 ± 
11.3 (5, n=77) 
Type IIa: 32.6 ± 
10.7 (2, n=19) 
Type IIx: 10.3 ± 
2.7 (3, n=21) 
Type IIax: 6.3 ± 
8.1 (2, n=9) 
Denervated: 1.9 ± 
0.1 (2, n=22) 
Master 
Power 
- - 19.6 ± 
5.8 
(8, 
n=125) 
VL 60-69: 2.1 ± 
0.09 (n=21) 
VL 70-84: 1.96 ± 
0.08 (n=20) 
RF: 2.73 ± 0.37 
(n=7) 
VL 60-69: 7.99 
± 0.27 (n=21) 
VL 70-84: 7.38 
± 0.27 (n=20) 
US: 5250 ± 1080 
(n=7) 
Type I: 4750 ± 
1273 (4, n=34) 
Type IIa: 4755 ± 
1404 (4, n=34) 
Type IIx: 4019 ± 
990 (4, n=34) 
Type IIax: 
4120± 495 (3, 
n=27) 
Type I: 48.0 ± 8.0 
(5, n=59) 
Type IIa: 31.8 ± 
38 (3, n=59) 
Type IIx: 10.7 ± 
4.1 (5, n=59) 
Type IIax: 11.6 ± 
2.6 (2, n=52) 
Table 3) Body composition, muscle mass and morphology (mean ± SD) not included in a meta-analysis (e.g. fat-free mass, fat-mass, relative fat-mass 
(additional data ineligible to be included in meta-analysis), muscle thickness, fascicle length, muscle CSA, fibre area, fibre distribution). First number in the 
bracket indicates the number of studies that assessed that particular variable, the second number indicates the number of individuals assessed.  
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Figures  
Figure 1) PRISMA Flowchart detailing the article identification, screening and exclusion 
process.  
 
 
Figure 2) Forest plot of the results from a random-effects meta-analyses shown and mean 
difference with 95% CI on body fat % in old control, master power athletes, endurance 
trained young and young control. The vertical dotted line represents the body fat for the 
master endurance athletes. For each study the square represents the mean difference with the 
horizontal line indicating the upper and lower limits of the 95% CI. The size of the square 
indicates the relative weighted contribution of each study to the meta-analyses. The diamond 
in each section indicates the pooled mean difference for each respective group.  
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Master endurance athletes vs. old control: Heterogeneity: 7.11 (5.70, 8.52) Tau² = 5.36; Chi² 
= 71.00, df = 14 (P < 0.00001); I² = 80% Test for overall effect: Z = 9.89 (P < 0.00001) 
Master endurance athletes vs. master power athletes: -1.00 (-7.61, 5.61) Heterogeneity: Not 
applicable Test for overall effect: Z = 0.30 (P = 0.77) 
Master endurance athletes vs. young control: -0.22 (-3.72, 3.28) Heterogeneity: Tau² = 13.08; 
Chi² = 17.30, df = 5 (P = 0.004); I² = 71% Test for overall effect: Z = 0.12 (P = 0.90).  
Master endurance athletes vs. young endurance trained: -4.44 (-8.44, -0.43) Heterogeneity: 
Tau² = 15.10; Chi² = 16.76, df = 4 (P = 0.002); I² = 76% Test for overall effect: Z = 2.17 (P = 
0.03) 
 
Figure 3) Forest plot of the results from a random-effects meta-analyses shown and mean 
difference with 95% CI on VO2max (ml.kg-1.min-1) in old control, master power athletes, 
endurance trained young and young control. The vertical dotted line represents the VO2max 
for the master endurance athletes. For each study the square represents the mean difference 
with the horizontal line indicating the upper and lower limits of the 95% CI. The size of the 
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square indicates the relative weighted contribution of each study to the meta-analyses. The 
diamond in each section indicates the pooled mean difference for each respective group.  
Master endurance athletes vs. old control: -15.41 (-17.39, -13.43) Heterogeneity: Tau² = 
28.97; Chi² = 439.62, df = 31 (P < 0.00001); I² = 93% Test for overall effect: Z = 15.27 (P < 
0.00001).  
Master endurance athletes vs. master power athletes: -7.77 (-12.03, -3.50) Heterogeneity: 
Tau² = 9.37; Chi² = 6.54, df = 2 (P = 0.04); I² = 69% Test for overall effect: Z = 3.57 (P = 
0.0004).  
Master endurance athletes vs. young control: 0.55 (-4.88, 5.98) Heterogeneity: Tau² = 116.92; 
Chi² = 547.90, df = 15 (P < 0.00001); I² = 97% Test for overall effect: Z = 0.20 (P = 0.84).  
Master endurance athletes vs. young endurance trained: 16.79 (13.50, 20.09) Heterogeneity: 
Tau² = 31.81; Chi² = 128.46, df = 12 (P < 0.00001); I² = 91% Test for overall effect: Z = 9.99 
(P < 0.00001).   
 
Figure 4) Forest plot of the strength results from random-effects meta-analyses shown 
presented as standardised mean difference with 95% CI in master power athletes, old control, 
endurance trained young and young control. The vertical dotted line represents the master 
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endurance athletes. For each study the square represents the standardised mean difference 
with the horizontal line indicating the upper and lower limits of the 95% CI. The size of the 
circle indicates the relative weighted contribution of each study to the meta-analyses. The 
diamond in each section indicates the pooled mean difference for each respective group.  
Master endurance athletes vs. master power athletes: 0.60 [0.28, 0.93] Heterogeneity: Tau² = 
0.00; Chi² = 3.68, df = 4 (P = 0.45); I² = 0% Test for overall effect: Z = 3.63 (P = 0.0003). 
Master endurance athletes vs. old control: -0.25 [-0.77, 0.27] Heterogeneity: Tau² = 0.48; 
Chi² = 36.17, df = 8 (P < 0.0001); I² = 78% Test for overall effect: Z = 0.93 (P = 0.35).  
Master endurance athletes vs. young control: 0.71 [0.06, 1.36] Heterogeneity: Tau² = 0.47; 
Chi² = 18.91, df = 5 (P = 0.002); I² = 74% Test for overall effect: Z = 2.13 (P = 0.03).  
Master endurance athletes vs. young endurance trained: 0.75 [-0.34, 1.85] Heterogeneity: 
Tau² = 0.78; Chi² = 12.12, df = 2 (P = 0.002); I² = 84% Test for overall effect: Z = 1.35 (P = 
0.18). 
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